Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults-Reference-Cited by-同舟云学术

Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults

Published:2018-11-14 Issue:6 Volume:8 Page:721-733
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Li Yan¹,Li Huafang¹,Sheng Yucheng²,Du Xin³,Yao Yuhui²,Luo Xian²,Ma Peiming²

Affiliation:

1. Shanghai Mental Health Center, Shanghai Key Laboratory of Psychotic Disorders; Shanghai Jiao Tong University School of Medicine; Xuhui Qu Shanghai China

2. Research and Development; GSK; Pudong Xinqu Shanghai China

3. Research and Development; GSK; Chaoyang District Beijing China

Funder

GlaxoSmithKline foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.626/fullpdf

Reference42 articles.

1. WHO Global surveillance, prevention and control of chronic respiratory diseases 2007 http://www.who.int/respiratory/publications/crd_strategy/en/

2. A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013: findings from the Global Burden of Disease study 2013;Yin;Chest,2016

3. Asthma research in China: a five-year review;Chen;Respirology,2013

4. The changing epidemiology of asthma in Shanghai, China;Zhang;J Asthma,2015

5. GOLD Global strategy for the diagnosis, management and prevention of COPD 2017 http://goldcopd.org

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD;Expert Review of Clinical Pharmacology;2022-03-04